iBio (IBIO) Non Operating Interest Expenses (2009 - 2026)
iBio (IBIO) reported Non Operating Interest Expenses of -$46,000 for fiscal Q4 2026 (quarter ended Jun 30, 2026), compared with $44,000 a year earlier.
Powered by 
Analysis
iBio (IBIO) Non Operating Interest Expenses (2009 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), iBio posted Non Operating Interest Expenses of $53,000, down 75.0% from FY2025.
- Non Operating Interest Expenses has a five-year compound annual growth rate of -53.6% (FY2021 to FY2026).
- By fiscal year, Non Operating Interest Expenses came in at $212,000 in FY2025 (+23.3%), $172,000 in FY2024 (+107.2%), $83,000 in FY2023 (-94.1%) and $1.41 million in FY2022 (-42.5%).
- The fiscal Q4 2026 figure ranks as the lowest quarterly Non Operating Interest Expenses in data going back to fiscal Q1 2011.
- Year over year, Non Operating Interest Expenses gained in three of the last seven quarters, with growth averaging 5.7%.
- The high point for year-over-year Non Operating Interest Expenses in five years was fiscal Q4 2024 (growth of 252.9%); the low point was fiscal Q4 2023 (a decline of 92.4%).
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at $22,000 (Q3 2026), $41,000 (Q2 2026) and $36,000 (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 217.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -477.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 653.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 269.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | iBio | 118.23 Mn | -174.02 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -46,000.00 |
| Mar 31, 2026 | 22,000.00 |
| Dec 31, 2025 | 41,000.00 |
| Sep 30, 2025 | 34,000.00 |
| Jun 30, 2025 | 44,000.00 |
| Mar 31, 2025 | 54,000.00 |
| Dec 31, 2024 | 57,000.00 |
| Sep 30, 2024 | 57,000.00 |
| Jun 30, 2024 | 60,000.00 |
| Mar 31, 2024 | 52,000.00 |
| Dec 31, 2023 | 34,000.00 |
| Sep 30, 2023 | 26,000.00 |
| Jun 30, 2023 | 17,000.00 |
| Mar 31, 2023 | 35,000.00 |
| Dec 31, 2022 | 31,000.00 |
| Jun 30, 2022 | 225,000.00 |
| Sep 30, 2021 | 609,000.00 |
| Jun 30, 2021 | 613,000.00 |
| Mar 31, 2021 | 612,000.00 |
| Dec 31, 2020 | 615,000.00 |
API Access
iBio Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=IBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "IBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=IBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();